Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P67
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1.58 | +58.5% |
| 2024 | -3.81 | -253.2% |
| 2023 | 2.49 | +162.4% |
| 2022 | -3.99 | -847.1% |
| 2021 | -0.42 | -106.3% |
| 2020 | 6.69 | +172.9% |
| 2019 | -9.18 | -220.8% |
| 2018 | -2.86 | +51.4% |
| 2017 | -5.88 | +16.2% |
| 2016 | -7.02 | - |